GlassScriptPhysician profile
Fikret I Atamdede
NPI 1578502480
$13,188.50
in general payments reported to CMS, 2019-2025
51 companies · $596 in 2025
The $596 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,397 · 2020: $1,186 · 2021: $1,943 · 2022: $2,250 · 2023: $2,431 · 2024: $1,386 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,431 · Travel and Lodging: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,431.40 |
| Travel and Lodging | $980.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,714.70 | 2019-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,374.29 | 2019-2025 | Lynparza |
| Glaxosmithkline, LLC. | $1,249.35 | 2020-2025 | Jemperli, Zejula |
| Medtronic, INC. | $1,153.45 | 2021-2024 | Ligasure, Sonicision, Signia |
| Abbvie INC. | $838.00 | 2019-2025 | |
| Covidien LP | $807.37 | 2019 | |
| Baxter Healthcare | $621.73 | 2019-2025 | Perclot |
| Myriad Genetic Laboratories, INC. | $547.97 | 2020-2024 | Myrisk, Precisetumor |
| New Wave Endo-Surgical Corp. | $464.00 | 2022 | |
| Coloplast Corp | $443.11 | 2019-2021 | |
| Eisai INC. | $388.95 | 2019-2025 | |
| Seagen INC. | $365.52 | 2020-2023 | Tukysa |
| Merck Sharp & Dohme LLC | $347.81 | 2019-2025 | Keytruda |
| Biom'Up France Sas | $289.74 | 2020-2021 | |
| Tesaro, INC. | $221.98 | 2019 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $193.30 | 2019-2020 | |
| Boston Scientific Corporation | $175.05 | 2019-2025 | Upsylon, Bulkamid |
| Caris Mpi, INC. | $164.93 | 2025 | Mi Cancer Seek |
| Ethicon US, LLC | $147.72 | 2019-2023 | Echelon; Endopath |
| Acell, INC. | $134.73 | 2019-2020 | |
| Allergan, INC. | $128.63 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2019 | |
| Pfizer INC. | $120.74 | 2024-2025 | |
| Helsinn Therapeutics (U.S.), INC. | $118.90 | 2019-2024 | Akynzeo |
| E.R. Squibb & Sons, L.L.C. | $91.54 | 2021 | |
| Integra Lifesciences Corporation | $89.50 | 2022-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Gynesonics, INC. | $77.76 | 2021 | |
| Immunogen, INC. | $75.13 | 2023-2024 | Elahere, Elahere |
| Sumitomo Pharma America, INC. | $72.38 | 2023-2025 | Myfembree |
| Musculoskeletal Transplant Foundation INC. | $49.10 | 2021 | |
| Urgo Medical North America, LLC | $47.83 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Genentech USA, INC. | $46.99 | 2019 | |
| Dysis Medical, INC. | $43.60 | 2021 | |
| Coopersurgical, INC. | $41.39 | 2022 | |
| Momentis Surgical INC. | $39.00 | 2022 | |
| Amgen INC. | $38.75 | 2019 | |
| Avanos Medical | $36.63 | 2019 | |
| Tempus Ai, INC | $29.84 | 2025 | Xt Cdx |
| Minerva Surgical, INC | $28.87 | 2023 | |
| Myovant Sciences INC. | $28.40 | 2022 | |
| Olympus America INC. | $28.17 | 2021 | |
| Daiichi Sankyo INC. | $26.85 | 2025 | Enhertu |
| Heron Therapeutics, INC. | $24.14 | 2021 | |
| Foundation Medicine, INC. | $23.06 | 2020 | |
| Amneal Pharmaceuticals LLC | $21.71 | 2023 | Neupogen, Avastin, Neulasta |
| Smith+Nephew, INC. | $20.77 | 2023 | Stravix |
| Conmed Corporation | $18.58 | 2024 | Airseal |
| Mylan Institutional INC. | $14.06 | 2019 | |
| Agiliti Surgical, INC. | $13.62 | 2019 | |
| Trevena, INC. | $12.14 | 2021 | |
| Astellas Pharma US INC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fikret Atamdede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.